Article Information
- Received October 14, 2008
- Revision received February 5, 2008
- Accepted February 6, 2009
- First published April 1, 2009.
- Version of record published April 1, 2009.
Author Information
- Marina Snapyan1,*,
- Morgane Lemasson1,*,
- Monika S. Brill3,4,
- Mathieu Blais5,
- Mireille Massouh1,2,
- Jovica Ninkovic3,4,
- Claude Gravel2,6,
- François Berthod5,
- Magdalena Götz3,4,
- Philip A. Barker7,
- André Parent2, and
- Armen Saghatelyan1,6
- 1The Cellular Neurobiology Unit and
- 2The Systemic Neurobiology Unit, Centre de Recherche Université Laval Robert-Giffard, Québec, Québec, Canada G1J 2G3,
- 3Department of Physiological Genomics, Institute of Physiology and Center for Integrated Protein Science Munich, Ludwig Maximilian University Munich, D-80336 Munich, Germany,
- 4Institute for Stem Cell Research, Helmholtz Zentrum München–National Research Center for Environmental Health, D-85764 Neuherberg/Munich, Germany,
- 5Laboratoire d'Organogénèse Expérimentale, Centre Hospitalier Affilié Universitaire de Québec, Département de Chirurgie, Université Laval, Hôpital du Saint-Sacrement, Québec, Canada G1S 4L8,
- 6Departement of Psychiatry, Université Laval, Québec, Québec, Canada G1K 7P4, and
- 7Montreal Neurological Institute, McGill University, Montreal, Québec, Canada H3A 2B4
- Correspondence should be addressed to Armen Saghatelyan, Centre de Recherche Université Laval Robert-Giffard, Université Laval, 2601 Chemin de la Canardiere, Quebec, Quebec, Canada G1J 2G3. armen.saghatelyan{at}crulrg.ulaval.ca
Author contributions
-
↵*M.S. and M.L. contributed equally to this work.
Disclosures
- Received October 14, 2008.
- Revision received February 5, 2008.
- Accepted February 6, 2009.
-
This work was supported by Canada Foundation for Innovation (CFI), Parkinson Society Canada, and Canadian Institutes of Health Research (CIHR) grants (A.S.). A.S. is a recipient of a Canada Research Chair in postnatal neurogenesis. We thank Drs. S. Nakamura (National Institute of Neuroscience, Tokyo, Japan), E. Castren (University of Helsinki, Helsinki, Finland) for providing BDNF plasmids, Dr. M. Kojima (National Institute of Advanced Science and Technology, Ikeda, Japan) for providing BDNF–GFP plasmid, Dr. J. Lee (Harvard Gene Therapy Initiative, Harvard Medical School, Boston, MA) for providing defective retroviral vector pMMP–f2–IRES–EGFP, and Drs. Freda Miller, Alain Trembleau, and Isabelle Caille for the comments on a previous version of this manuscript.
- Correspondence should be addressed to Armen Saghatelyan, Centre de Recherche Université Laval Robert-Giffard, Université Laval, 2601 Chemin de la Canardiere, Quebec, Quebec, Canada G1J 2G3. armen.saghatelyan{at}crulrg.ulaval.ca
Online Impact